AnalystsLaura SutcliffeLaura Sutcliffe's Stock Forecasts
AnalystsLaura Sutcliffe
Analyst Ranking
Bottom 14%
#4598 out of 5292 analysts
Average Return
-12.54%
Win Rate
33%3 out of 9
Risk vs Reward
Poor
Good
Laura Sutcliffe's 5 best and worst ratings
Laura Sutcliffe Analyst Color
Get additional color on Laura Sutcliffe's coverage of popular stocks
Laura Sutcliffe's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Resmed IncRMD | 5 | Strong Buy | $340.00 | +76.04% | Maintains | 2 months ago |
Telix Pharmaceuticals LtdTLX | 3 | Strong Buy | $22.50 | +144.03% | Maintains | 4 months ago |
Banco Santander SaSAN | 1 | Hold | N/A | N/A | Downgrades | 4 years ago |
Ucb SaUCBJY | 1 | Strong Buy | N/A | N/A | Upgrades | 5 years ago |
Argenx SeARGX | 1 | Strong Buy | $390.00 | N/A | Initiates Coverage On | 5 years ago |
Vifor Pharma AgGNHAF | 1 | Hold | N/A | N/A | Upgrades | 5 years ago |
Lakefront Biotherapeutics NvLKFT | 1 | Hold | N/A | N/A | Downgrades | 6 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.